University of Michigan, Ann Arbor, MI, USA.
Eur J Heart Fail. 2010 Jun;12(6):566-73. doi: 10.1093/eurjhf/hfq043. Epub 2010 Mar 30.
To determine the association between obesity and outcomes in post-acute myocardial infarction (AMI) patients with systolic heart failure (HF).
Of the 6632 Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) participants, 6611 had data on baseline body mass index (BMI) and 6561 had BMI > or = 18.5 kg/m(2). Of these, 1573 were obese (BMI > or = 30 kg/m(2)) and 4988 were non-obese (BMI 18.5-29.9 kg/m(2)). Propensity scores for obesity, estimated for each patient, were used to assemble a cohort of 1519 pairs of obese and non-obese patients who were balanced on 65 baseline characteristics. All-cause mortality occurred in 13.7 and 13.8% of matched obese and non-obese patients, respectively, during 16 months of median follow-up [matched hazard ratio (HR) for obesity 0.98; 95% confidence interval (CI) 0.79-1.21; P = 0.831]. Before matching, the obese group was younger (mean age, 62 vs. 64 years; P < 0.0001) and had more women (37 vs. 26%; P < 0.0001). The paradoxical pre-match association between obesity and reduced mortality (unadjusted HR 0.82; 95% CI 0.70-0.95; P = 0.008) disappeared when adjusted for age alone (age-adjusted HR 0.91; 95% CI 0.78-1.06; P = 0.206) but not for gender alone (gender-adjusted HR 0.79; 95% CI 0.68-0.92; P = 0.003). Obesity had no association with mortality in 1573 pairs of age-matched obese and non-obese patients (age-adjusted HR 0.94; 95% CI 0.77-1.13; P = 0.484).
In post-AMI patients with systolic HF, obesity provides no independent intrinsic survival benefit. The paradoxical unadjusted survival associated with obesity is largely explained by the younger age of obese patients.
确定肥胖与收缩性心力衰竭(HF)的急性心肌梗死(AMI)后患者结局之间的相关性。
在依普利酮急性心肌梗死后心力衰竭生存疗效研究(EPHESUS)的 6632 名参与者中,有 6611 名患者有基线体重指数(BMI)数据,6561 名患者 BMI 大于或等于 18.5kg/m(2)。其中,1573 名患者为肥胖(BMI 大于或等于 30kg/m(2)),4988 名患者为非肥胖(BMI 为 18.5-29.9kg/m(2))。为每个患者估算肥胖的倾向评分,用于组装 1519 对肥胖和非肥胖患者的队列,这些患者在 65 项基线特征上是平衡的。在中位随访 16 个月期间,肥胖和非肥胖患者的全因死亡率分别为 13.7%和 13.8%[肥胖的匹配危险比(HR)为 0.98;95%置信区间(CI)为 0.79-1.21;P = 0.831]。在匹配之前,肥胖组更年轻(平均年龄 62 岁与 64 岁;P < 0.0001),女性更多(37%与 26%;P < 0.0001)。肥胖与死亡率降低之间的这种矛盾的匹配前关联(未调整 HR 0.82;95%CI 0.70-0.95;P = 0.008),在仅调整年龄时(年龄调整 HR 0.91;95%CI 0.78-1.06;P = 0.206)消失,但仅调整性别时(性别调整 HR 0.79;95%CI 0.68-0.92;P = 0.003)并未消失。在 1573 对年龄匹配的肥胖和非肥胖患者中,肥胖与死亡率无相关性(年龄调整 HR 0.94;95%CI 0.77-1.13;P = 0.484)。
在 AMI 后伴有收缩性 HF 的患者中,肥胖并不能提供独立的内在生存获益。肥胖与未调整生存之间的这种矛盾关联在很大程度上可以用肥胖患者的年龄较小来解释。